These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
83 related items for PubMed ID: 7852482
1. P53 protein accumulates in Cushings adenomas and invasive non-functional adenomas. Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW, Clayton RN. J Clin Endocrinol Metab; 1995 Feb; 80(2):4 p following 692. PubMed ID: 7852482 [Abstract] [Full Text] [Related]
2. p53 Protein accumulates in Cushings adenomas and invasive non-functional adenomas. Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW, Clayton RN. J Clin Endocrinol Metab; 1994 Nov; 79(5):1513-6. PubMed ID: 7962351 [Abstract] [Full Text] [Related]
3. p53 gene mutations in pituitary adenomas: rare events. Levy A, Hall L, Yeudall WA, Lightman SL. Clin Endocrinol (Oxf); 1994 Dec; 41(6):809-14. PubMed ID: 7889618 [Abstract] [Full Text] [Related]
4. Expression of p53 protein in pituitary adenomas. Oliveira MC, Marroni CP, Pizarro CB, Pereira-Lima JF, Barbosa-Coutinho LM, Ferreira NP. Braz J Med Biol Res; 2002 May; 35(5):561-5. PubMed ID: 12011941 [Abstract] [Full Text] [Related]
5. Immunocytochemical accumulation of p53 in corticotroph adenomas: relationship with heat shock proteins and apoptosis. Kontogeorgos G, Kapranos N, Thodou E, Sambaziotis D, Tsagarakis S. Pituitary; 1999 May; 1(3-4):207-12. PubMed ID: 11081199 [Abstract] [Full Text] [Related]
6. Histone acetylation patterns of typical and atypical pituitary adenomas indicate epigenetic shift of these tumours. Ebrahimi A, Schittenhelm J, Honegger J, Schluesener HJ. J Neuroendocrinol; 2011 Jun; 23(6):525-30. PubMed ID: 21453398 [Abstract] [Full Text] [Related]
7. Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenomas. Green VL, White MC, Hipkin LJ, Jeffreys RV, Foy PM, Atkin SL. Eur J Endocrinol; 1997 Apr; 136(4):382-7. PubMed ID: 9150697 [Abstract] [Full Text] [Related]
8. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas]. Miyagami M, Nakamura S. No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195 [Abstract] [Full Text] [Related]
9. Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland. Turner HE, Nagy Z, Sullivan N, Esiri MM, Wass JA. Clin Endocrinol (Oxf); 2000 Sep; 53(3):337-44. PubMed ID: 10971451 [Abstract] [Full Text] [Related]
10. Mutations of the p53 gene in human functional adrenal neoplasms. Lin SR, Lee YJ, Tsai JH. J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638 [Abstract] [Full Text] [Related]
11. Biologic markers of invasive pituitary adenomas involving the sphenoid sinus. Gandour-Edwards R, Kapadia SB, Janecka IP, Martinez AJ, Barnes L. Mod Pathol; 1995 Feb; 8(2):160-4. PubMed ID: 7777477 [Abstract] [Full Text] [Related]
12. Immunohistochemical analysis of p53 overexpression in human colonic tumors. Darmon E, Cleary KR, Wargovich MJ. Cancer Detect Prev; 1994 Feb; 18(3):187-95. PubMed ID: 8076381 [Abstract] [Full Text] [Related]
13. Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas: an immunocytochemical study. Tsagarakis S, Kontogeorgos G, Giannou P, Thalassinos N, Woolley J, Besser GM, Grossman A. Clin Endocrinol (Oxf); 1992 Aug; 37(2):163-7. PubMed ID: 1327588 [Abstract] [Full Text] [Related]
14. Analysis of the in vitro secretory activity of human pituitary adenomas: modification of corticotropin release from adenoma tissue explant cultures by addition of a human plasma ultrafiltrate bioactive fraction. Zarković N, Hayn M, Plavsić V, Zarković K, Paladino J, Hirsl N, Golubić J, Mikulandra S, Rogić D, Salzer B, Pokrić B, Schaur RJ, Tatzber F, Faulhammer H, Benko B, Dietrich W, Jurin M, Korsić M. Eur J Clin Chem Clin Biochem; 1996 Jan; 34(1):23-30. PubMed ID: 8704030 [Abstract] [Full Text] [Related]
15. Expression of pituitary tumour-derived, N-terminally truncated isoform of fibroblast growth factor receptor 4 (ptd-FGFR4) correlates with tumour invasiveness but not with G-protein alpha subunit (gsp) mutation in human GH-secreting pituitary adenomas. Morita K, Takano K, Yasufuku-Takano J, Yamada S, Teramoto A, Takei M, Osamura RY, Sano T, Fujita T. Clin Endocrinol (Oxf); 2008 Mar; 68(3):435-41. PubMed ID: 18070145 [Abstract] [Full Text] [Related]
16. p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws ER. Neurosurgery; 1996 Apr; 38(4):765-70; discussion 770-1. PubMed ID: 8692397 [Abstract] [Full Text] [Related]
17. Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours. Dahia PL, Aguiar RC, Honegger J, Fahlbush R, Jordan S, Lowe DG, Lu X, Clayton RN, Besser GM, Grossman AB. Oncogene; 1998 Jan 08; 16(1):69-76. PubMed ID: 9467944 [Abstract] [Full Text] [Related]
18. P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas. Hentschel SJ, McCutcheon lE, Moore W, Durity FA. Can J Neurol Sci; 2003 Aug 08; 30(3):215-9. PubMed ID: 12945944 [Abstract] [Full Text] [Related]
19. p53 expression in colorectal adenomas. Kaklamanis L, Gatter KC, Mortensen N, Baigrie RJ, Heryet A, Lane DP, Harris AL. Am J Pathol; 1993 Jan 08; 142(1):87-93. PubMed ID: 7678722 [Abstract] [Full Text] [Related]
20. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome. Turner HE, Nagy Z, Gatter KC, Esiri MM, Harris AL, Wass JA. J Endocrinol; 2000 May 08; 165(2):475-81. PubMed ID: 10810311 [Abstract] [Full Text] [Related] Page: [Next] [New Search]